Biofrontera Inc. announced the appointment of Samantha (Sam) Widdicombe to the newly created position of Senior Director, Strategic Accounts and Communications. Biofrontera created this position in response to the growing demand and opportunity for specialized sales and marketing approaches resulting from an evolving landscape of medical practices consolidating into larger integrated organizations. Reporting to Mark Baldyga, Vice President of Sales and Marketing, Ms. Widdicombe joins Biofrontera with over 25 years of commercial leadership experience in the pharmaceutical industry, including 12 years in dermatology.

She began her career in the United Kingdom with roles of increasing responsibility in sales and marketing before moving to the U.S. in 2011. Prior to joining Biofrontera, Ms. Widdicombe was Head of Strategic Communications at EPI Health/Novan and previously served as Executive Director at Almirall, where she established their U.S. corporate communications function. Ms. Widdicombe began her career in dermatology at Allergan, where she was responsible for peer-to-peer initiatives for the medical dermatology franchise including Aczone®, Tazorac® and Rhofade®, and Skinmedica.

Before relocating to the U.S., she was Director of European Marketing and led a UK business unit for GE Healthcare. Ms. Widdicombe holds a BSc in Biochemistry from the University of Birmingham in England.